Lutetium-177 is a drug used for which type of tumor?

Lutetium-177 is a radioactive isotope commonly used in radionuclide therapy. Generally, lutetium-177 is employed as a medication for neuroendocrine tumors. If physical discomfort occurs, it is recommended to seek medical evaluation and follow the doctor's advice for appropriate treatment. The detailed analysis is as follows:

The primary application of lutetium-177 therapy is in the treatment of neuroendocrine tumors, particularly pancreatic neuroendocrine tumors and other pancreatic tumors. The mechanism involves binding lutetium-177 to octreotide, which targets tumor cells and releases radiation energy to destroy cancer cells. This treatment approach has demonstrated favorable efficacy in treating pancreatic neuroendocrine tumors and other types of neuroendocrine tumors, especially in cases of metastatic disease or tumors that cannot be surgically removed. It can help control tumor growth and improve both patient survival rates and quality of life.

The specific treatment plan must be individually tailored based on the patient's condition, tumor type, and personal circumstances.